Form 8-K - Current report:
SEC Accession No. 0000950103-24-002027
Filing Date
2024-02-12
Accepted
2024-02-12 08:37:51
Documents
18
Period of Report
2024-02-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp206638_8k.htm   iXBRL 8-K 44304
2 EXHIBIT 2.1 dp206638_ex0201.htm EX-2.1 542853
3 EXHIBIT 99.1 dp206638_ex9901.htm EX-99.1 25465
4 GRAPHIC image_001.jpg GRAPHIC 6885
5 GRAPHIC image_002.jpg GRAPHIC 247077
  Complete submission text file 0000950103-24-002027.txt   1257322

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE gild-20240211.xsd EX-101.SCH 3009
7 XBRL LABEL FILE gild-20240211_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE gild-20240211_pre.xml EX-101.PRE 22355
20 EXTRACTED XBRL INSTANCE DOCUMENT dp206638_8k_htm.xml XML 3503
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 24617510
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)